4.5 Article

Role of AT1 receptor-mediated salt retention in angiotensin II-dependent hypertension

Journal

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
Volume 301, Issue 5, Pages F1124-F1130

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajprenal.00305.2011

Keywords

kidney diseases

Funding

  1. National Institutes of Health [DK087893-01]
  2. Medical Research Service of the Veterans Administration
  3. Edna and Fred L. Mandel Center for Hypertension and Atherosclerosis Research

Ask authors/readers for more resources

Crowley SD, Zhang J, Herrera M, Griffiths R, Ruiz P, Coffman TM. Role of AT(1) receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Renal Physiol 301: F1124-F1130, 2011. First published August 17, 2011; doi:10.1152/ajprenal.00305.2011.-Activation of type 1 angiotensin II (AT(1)) receptors in the kidney promotes blood pressure elevation and target organ damage, but whether renal AT(1) receptors influence the level of hypertension by stimulating sodium retention or by raising systemic vascular resistance has not been established. In the current studies, we used a kidney cross-transplantation strategy to determine whether increased sodium reabsorption by AT(1) receptors in the kidney mediates the chronic hypertensive response to angiotensin II. We found this to be true. In addition, we also identified a second, nontrivial component of blood pressure elevation induced by activation of renal AT(1) receptors that is sodium-independent. As the kidney has the capacity to limit the transmission of elevated systemic blood pressure into the renal microcirculation, prior studies struggled to clearly discriminate the relative contributions of blood pressure elevation vs. activation of AT(1) receptors to hypertensive kidney injury. In our model, we found that rapid surges in blood pressure, which may overcome the kidney's capacity to prevent perturbations in renal hemodynamics, correlate closely with kidney damage in hypertension. Moreover, maximal kidney injury in hypertension may require activation of a pool of nonrenal, systemic AT(1) receptors. These studies provide insight into precise mechanisms through which AT(1) receptor blockade influences the progression of hypertensive kidney disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available